OS Therapies Inc’s (NYSE:OSTX) Quiet Period To End on September 10th

OS Therapies’ (NYSE:OSTX) quiet period will end on Tuesday, September 10th. OS Therapies had issued 1,600,000 shares in its initial public offering on August 1st. The total size of the offering was $6,400,000 based on an initial share price of $4.00. During the company’s quiet period, insiders and any underwriters involved in the IPO are prevented from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the expiration of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Analyst Ratings Changes

Separately, Brookline Capital Management raised OS Therapies to a “strong-buy” rating in a research note on Thursday, August 22nd.

OS Therapies Trading Up 4.0 %

OSTX opened at $4.12 on Thursday. OS Therapies has a 12 month low of $2.51 and a 12 month high of $4.90.

OS Therapies (NYSE:OSTX) last released its quarterly earnings data on Wednesday, August 14th. The company reported ($0.26) EPS for the quarter. As a group, equities research analysts predict that OS Therapies will post -0.47 earnings per share for the current year.

OS Therapies Company Profile

OS Therapies Incorporated is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. Our mission is to address the significant need for new treatments in cancers of the bone in children and young adults.